PDTM-48. PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMA

Group-3 medulloblastoma (MBL), one of the most common malignant pediatric brain tumors, is highly resistant to radiation and chemotherapy and have the worst prognosis. Hence, there is an urgent need to elucidate targets that can sensitize these tumors to conventional chemotherapy and radiation. We i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Babu, Sajesh, Omar, Refaat, Fediuk, Holly, Li, Lin, Coudiere-Morrision, Ludivine, Wang, W, Pu, J, Sun, H D, Werbowetski-Ogilvie, Tamra, Wölfl, Matthias, Remke, Marc, Taylor, Michael, Eberhart, Charles, Symons, Marc, Ruggieri, Rosamaria, Vanan, Magimairajan Issai
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692400/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.810
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars